Stock YMAB Y-MABS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Y-mAbs Therapeutics, Inc.

Equities

YMAB

US9842411095

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
11.98 USD -2.68% Intraday chart for Y-mAbs Therapeutics, Inc. -0.99% +75.66%
Jun. 05 Y-mAbs Therapeutics, Inc. Appoints Norman LaFrance as Chief Development Officer CI
Jun. 01 Y-mAbs Therapeutics, Inc. Announces Publication of Preclinical GD2-SADA Data CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. YMAB Stock
  4. Revisions Y-mAbs Therapeutics, Inc.